Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Novel mouse models of hepatocarcinogenesis with stepwise accumulation of genetic alterations.

Kim SK, Marusawa H, Eso Y, Chiba T, Kudo M.

Dig Dis. 2013;31(5-6):454-8. doi: 10.1159/000355244. Review.

PMID:
24281020
2.

Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis.

Kou T, Marusawa H, Kinoshita K, Endo Y, Okazaki IM, Ueda Y, Kodama Y, Haga H, Ikai I, Chiba T.

Int J Cancer. 2007 Feb 1;120(3):469-76.

3.

Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.

Ikeda A, Shimizu T, Matsumoto Y, Fujii Y, Eso Y, Inuzuka T, Mizuguchi A, Shimizu K, Hatano E, Uemoto S, Chiba T, Marusawa H.

Gastroenterology. 2014 Jan;146(1):222-32.e35. doi: 10.1053/j.gastro.2013.09.025.

PMID:
24055508
4.

A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations.

Takai A, Toyoshima T, Uemura M, Kitawaki Y, Marusawa H, Hiai H, Yamada S, Okazaki IM, Honjo T, Chiba T, Kinoshita K.

Oncogene. 2009 Jan 29;28(4):469-78. doi: 10.1038/onc.2008.415.

PMID:
18997814
5.

Activation-induced cytidine deaminase is dispensable for virus-mediated liver and skin tumor development in mouse models.

Nguyen T, Xu J, Chikuma S, Hiai H, Kinoshita K, Moriya K, Koike K, Marcuzzi GP, Pfister H, Honjo T, Kobayashi M.

Int Immunol. 2014 Jul;26(7):397-406. doi: 10.1093/intimm/dxu040.

6.

Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma.

Nishida N, Kudo M.

Oncology. 2013;84 Suppl 1:93-7. doi: 10.1159/000345897. Review.

PMID:
23428866
7.

Detection of epigenetic aberrations in the development of hepatocellular carcinoma.

Zhang Y.

Methods Mol Biol. 2015;1238:709-31. doi: 10.1007/978-1-4939-1804-1_37. Review.

PMID:
25421688
8.

Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma.

Tao R, Li J, Xin J, Wu J, Guo J, Zhang L, Jiang L, Zhang W, Yang Z, Li L.

PLoS One. 2011;6(5):e19862. doi: 10.1371/journal.pone.0019862.

9.

Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.

Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Domany E, Galun E, Goldenberg D.

Mol Cancer Res. 2007 Nov;5(11):1159-70.

10.

Genetic and epigenetic events in human hepatocarcinogenesis.

Kondoh N, Wakatsuki T, Hada A, Shuda M, Tanaka K, Arai M, Yamamoto M.

Int J Oncol. 2001 Jun;18(6):1271-8. Review.

PMID:
11351262
11.

Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish.

Lu JW, Yang WY, Tsai SM, Lin YM, Chang PH, Chen JR, Wang HD, Wu JL, Jin SL, Yuh CH.

PLoS One. 2013 Oct 9;8(10):e76951. doi: 10.1371/journal.pone.0076951.

12.

Human hepatocyte carcinogenesis (review).

Shiraha H, Yamamoto K, Namba M.

Int J Oncol. 2013 Apr;42(4):1133-8. doi: 10.3892/ijo.2013.1829. Review.

13.

HBV induced carcinogenesis.

Cougot D, Neuveut C, Buendia MA.

J Clin Virol. 2005 Dec;34 Suppl 1:S75-8. Review.

PMID:
16461228
14.

[Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].

Xue KX.

Ai Zheng. 2005 Jun;24(6):757-68. Review. Chinese.

PMID:
15946497
15.

Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.

Koike K.

J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S108-11. Review. Erratum in: J Gastroenterol Hepatol. 2008 Mar;23(3):501-2.

PMID:
17567457
16.

Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.

Ringelhan M, Heikenwalder M, Protzer U.

Dig Dis. 2013;31(1):138-51. doi: 10.1159/000347209. Review.

PMID:
23797136
18.

Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.

Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM.

Genomics. 2013 Aug;102(2):74-83. doi: 10.1016/j.ygeno.2013.04.001. Review.

19.

Early molecular and genetic determinants of primary liver malignancy.

Feitelson MA, Pan J, Lian Z.

Surg Clin North Am. 2004 Apr;84(2):339-54. Review.

PMID:
15062649
20.

Hepatocellular carcinoma: an update.

Dominguez-Malagón H, Gaytan-Graham S.

Ultrastruct Pathol. 2001 Nov-Dec;25(6):497-516. Review.

PMID:
11783914
Items per page

Supplemental Content

Support Center